Inj, romiplostim 1 microgram
Products billed under this code include Nplate.
Payment limit per 1 MCG, by effective quarter, 1Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Nplate.
Payment limit per 1 MCG, by effective quarter, 1Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Nplate | Amgen Inc | 55513-0221-01 | 250 | $2,928.25 |
| Nplate | Amgen Inc | 55513-0222-01 | 500 | $5,856.50 |
| Nplate | Amgen Inc | 55513-0223-01 | 125 | $1,464.125 |
| Nplate | Amgen Inc | 55513-0223-21 | 125 | $1,464.125 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $11.713 | +$0.096 | 1 MCG | Inj, romiplostim 1 microgram | v1, posted September 17, 2026 |
| 3Q26 | $11.617 | +$0.51 | 1 MCG | Inj, romiplostim 1 microgram | v1, posted September 15, 2026 |
| 2Q26 | $11.107 | +$0.059 | 1 MCG | Inj, romiplostim 1 microgram | v1, posted September 15, 2026 |
| 1Q26 | $11.048 | +$0.035 | 1 MCG | Inj, romiplostim 1 microgram | v1, posted September 15, 2026 |
| 4Q25 | $11.013 | +$0.017 | 1 MCG | Inj, romiplostim 1 microgram | v1, posted September 8, 2026 |
| 3Q25 | $10.996 | +$0.48 | 1 MCG | Inj, romiplostim 1 microgram | v1, posted March 10, 2026 |
| 2Q25 | $10.516 | −$0.027 | 1 MCG | Inj, romiplostim 1 microgram | v1, posted March 10, 2026 |
| 1Q25 | $10.543 | – | 1 MCG | Inj, romiplostim 1 microgram | v1, posted December 19, 2025 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.